This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Seelos Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gopal Krishna: Innovator in Trehalose Formulations
Introduction
Gopal Krishna is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of trehalose formulations. His work focuses on innovative methods to treat mucopolysaccharidoses, a group of inherited metabolic disorders.
Latest Patents
Gopal Krishna holds a patent for "Trehalose formulations and uses thereof." This patent outlines methods for treating or alleviating symptoms of mucopolysaccharidoses by administering a trehalose formulation to affected subjects. He has 1 patent to his name, showcasing his commitment to advancing medical treatments.
Career Highlights
Gopal Krishna is currently employed at Seelos Therapeutics, Inc., where he continues to explore and develop therapeutic solutions. His work at this company emphasizes the importance of innovative approaches in addressing complex health issues.
Collaborations
Gopal has collaborated with notable colleagues, including Raj Mehra and Warren Wasiewski. These partnerships enhance the research and development efforts at Seelos Therapeutics, Inc., fostering a collaborative environment for innovation.
Conclusion
Gopal Krishna's contributions to the field of trehalose formulations highlight his dedication to improving treatment options for patients with mucopolysaccharidoses. His innovative work and collaborations position him as a key figure in the ongoing advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile